Abstract
Rights: UNKNOWN · http://onlinelibrary.wiley.com/termsAndConditions#vor · Source: journal-auto-sync:external:CROSSREF_ISSN
Stavros Petrou
Abstract
Rights: UNKNOWN · http://onlinelibrary.wiley.com/termsAndConditions#vor · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1002/hec.4730020106
10.1002/hec.4730020106
10.1136/jms.7.2.59
10.1136/jms.7.2.59
10.1016/0167-6296(87)90009-9
10.1016/0167-6296(87)90009-9
Unresolved referenced work
1980
10.1097/00005650-199105000-00007
10.1097/00005650-199105000-00007
Economic evaluation of preventive programmes against congenital toxoplasmosis
1992
10.3109/00016349309013380
10.3109/00016349309013380
Comparison of prevention strategies for neonatal group B streptococcal infection. A population‐based economic analysis
10.1001/jama.1993.03510120064032 · 1993
10.1002/hec.4730030104
10.1002/hec.4730030104
Cost‐benefit analysis of prenatal platelet PL (A1) typing
1995
10.5694/j.1326-5377.1995.tb139969.x
10.5694/j.1326-5377.1995.tb139969.x
10.3109/00365549509019020
10.3109/00365549509019020
10.1016/0029-7844(95)00097-b
10.1016/0029-7844(95)00097-b
A cost‐benefit analysis of prenatal screening for toxoplasmosis
1996
10.1016/0029-7844(96)00025-7
10.1016/0029-7844(96)00025-7
10.1136/jms.5.3.120
10.1136/jms.5.3.120
10.1086/302042
10.1086/302042
10.1016/s0029-7844(98)00221-x
10.1016/s0029-7844(98)00221-x
10.1016/s0029-7844(98)00035-0
10.1016/s0029-7844(98)00035-0
10.1002/hec.4730040602
10.1002/hec.4730040602
10.1177/0272989x9601600208
10.1177/0272989x9601600208
10.1136/bmj.2.6151.1571-a
10.1136/bmj.2.6151.1571-a
No additional external references are available.